Evidence map›Paper›PMID 28578669›Full record

ArticleRespiratory research2017

VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells.

Khadija Ourradi, Thomas Blythe, Caroline Jarrett, Shaney L Barratt, Gavin I Welsh, Ann B Millar

Open access · goldAbstract readComparative Study
In one paragraph

Article in Respiratory research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. VEGFAngiogenesis · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. The protective role of raltegravir in experimental acute lung injury in vitro and in vivo.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond.Journal of the American Heart Association · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Khadija OurradiAcademic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
Thomas BlytheAcademic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
Caroline JarrettAcademic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
Shaney L BarrattAcademic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
Gavin I WelshBristol Renal, School of Clinical Sciences, University of Bristol, Bistol, UK.
Ann B MillarAcademic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK. ann.millar@bristol.ac.uk.
University of Bristol · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundAlternative splicing of Vascular endothelial growth factor-A mRNA transcripts (commonly referred as VEGF) leads to the generation of functionally differing isoforms, the relative amounts of which have potentially significant physiological outcomes in conditions such as acute respiratory distress syndrome (ARDS). The effect of such isoforms on pulmonary vascular permeability is unknown. We hypothesised that VEGF

methodTo test this hypothesis we investigated the physiological effect of VEGF

resultsVEGF

conclusionThis study demonstrates that the novel isoform VEGF

Indexed as

Antigens, CDCadherin 5CadherinsCapillary PermeabilityCell MovementCell ProliferationCells, CulturedElectric ConductivityEndothelial CellsFluorescein-5-isothiocyanateHumansLungMicrovesselsMitogen-Activated Protein KinasesNitric Oxide Synthase Type IIIPhosphorylationAntigens, CDCadherin 5CadherinsFluorescein-5-isothiocyanatefluorescein isothiocyanate bovine serum albuminKDR protein, humanMitogen-Activated Protein KinasesNitric Oxide Synthase Type IIINOS3 protein, humanProtein IsoformsProto-Oncogene Proteins c-aktSerum Albumin, BovineVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Cell signallingVascular endothelial growth factor (VEGF)Vascular permeability

Identifiers

PMID28578669
PMCPMC5457598
OpenAlexW2620823272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.